Lv3
390 积分 2024-11-14 加入
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
8天前
已完结
Management of Symptomatic Uterine Leiomyomas
11天前
已完结
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy
12天前
已完结
Elimination of the hepatitis B virus: A goal, a challenge
28天前
已完结
New Approaches to Chronic Hepatitis B
28天前
已完结
Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study
1个月前
已完结
The use of oral GnRH antagonist to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization
2个月前
已完结
A critical evaluation of nemolizumab for prurigo nodularis
2个月前
已完结
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
2个月前
已完结
Approaches and rationale for the selection of a non-rodent species within a low molecular weight, early drug development program
3个月前
已完结
皖公网安备34019202002308
